Kochi A, Kashiwagi S, Nakada K, Gose A, et al. Clinical impact of the 21-gene recurrence score on adjuvant treatment selection in elderly patients with hormone receptor-positive, HER2-negative early breast cancer. BMC Cancer 2026 Apr 11. doi: 10.1186/s12885-026-15948.
PMID: 41965577